Powderful Oral Anabolic Steroids Methyltrienolone CAS: 965-93-5 for Muscle Gain

Powderful Oral Anabolic Steroids Methyltrienolone CAS: 965-93-5 for Muscle Gain

Description:

Methyltrienolone is an oral steroid that has never been sold as a prescription drug or a dietary supplement. Its only use at this point has been as a research chemical, although it does have some limited availability on the black market. Methyltrienolone is basically trenbolone with a C-17 methyl group making it orally bioavailable.

Like trenbolone methyltrienolone has an extremely strong binding affinity for the androgen receptor as well, even surpassing that of testosterone. This of course supports the assertion that trenbolone is extremely anabolic as by binding to the androgen receptor a compound is able to activate the anabolic mechanisms that are dependent upon the androgen receptor, one of the many ways that anabolic steroids aid muscle growth. Androgen receptors also exist in adipose tissue. When stimulated by way of a compound such as methyltrienolone binding to them, this can result in a higher then normal lipolytic action. So not only does this drug help to build muscle, it can help to burn fat.

Another rather unique characteristic of methyltrienolone is its anti-catabolic abilities. Methyltrienolone binds with the receptors that interact with glucocorticoid hormones, these being catabolic hormones. By being able to inhibit cortisol and some other catabolic hormones in the body methyltrienolone is ideal for those users that are attempting to reduce body fat as the compound will help to minimize muscle wasting when running a calorie deficit.

Specifications:

Methyltrienolone
Synonyms: Methyltrienolone; METRIBOLONE; R1881; 965-93-5; Metribolona; 17alpha-Methyltrienolone
Alias: Methyltrenbolone, METRIBOLONE, METHYLTRIENOLONE
CAS: 965-93-5
MF: C19H24O2
MW: 284.39
Assay: 99% min.
Effective dose: 500-750mcgs/day
Delivery: Express courier.
Character: White to light yellow crystalline powder.
Usage An anabolic steroid. pharmaceutical material, Steroid hormone, Anabolin.

2D Structure:

COA:

Background:

Methyltrienolone was first described in 1965.627 It was immediately identified as an extremely potent anabolic agent, far more potent than the commercially available agents of the time. In spite of its high relative activity, however, methyltrienolone has seen very limited use in humans. It was used clinically during the late 1960's and early '70's, most notably in the treatment of advanced breast cancer. Here, its exceedingly strong anabolic/androgenic action helps the drug counter the local effects of endogenous estrogens, lending it some efficacy for slowing or even regressing tumor growth. Such application was not long lived, however, as more realistic evaluations of the drug's toxicity soon led to its abandonment in human medicine. By the mid-1970's, methyltrienolone was becoming an accepted standard in non-human research studies, particularly those pertaining to the study of the androgen receptor activity. For this purpose the agent is very well suited. Its sheer potency and resistance to serum-binding proteins makes it an excellent in-vitro receptor-binding standard to compare other agents to. Being so resistant to metabolism, active methyltrienolone metabolites are also not going to greatly interfere with the results of most experiments. Body tissues can metabolize most steroids fairly easily, which means that even incubation studies can be complicated with the question of what is causing a particular effect, the steroid or one of its unidentified metabolites. This is much less of an issue with methyltrienolone. Today, methyltrienolone remains an agent of research use only.

Use:

Methyltrienolone was originally developed by a French pharmaceutical company, but never commercially produced due to its severe hepatoxic effects. That should indicate how truly harsh this drug is. For this reason it is important that users use caution when dosing this drug and ensure that they keep their cycles of it to brief periods of time. This would also include the exclusion of other steroids that are overly hepatoxic, such as 17 alpha alkylated oral steroids.

In terms of cycle duration, four weeks is the standard length that most users limit themselves too if not shorter. Any extension of this time would absolutely necessitate continuous blood tests conducted by a doctor, something that is a good idea no matter how long a user intends to run this drug. Of course, individual response to the drug and the liver function of a user would also factor into how well a user is able to tolerate methyltrienolone and thereby run the drug.

Dose:

MAN: At the very least, routine blood tests should be conducted to ensure the agent is not imparting damage. Drug duration should also be very limited, preferably to 4 weeks of use or less. The relative potency of methyltrienolone is extremely high, requiring doses as little as .5 milligram per day. Its effective and tolerable range is usually considered to be .5 to 2mg per day. Dianabol-type doses of 20-30 mg daily are completely unthinkable, and should never be attempted.

WOMAN: Methyltrienolone is no longer used in clinical medicine due to an unacceptable level of hepatotoxicity. This agent is not recommended for women for physique- or performance-enhancing purposes due to its extremely strong toxicity and tendency to produce virilizing side effects.

Conversion Recipes:

1gram Methyl Trenbolone 100ML @ 10mg/ml
97ml Ethyl Oleate
2ml Benzyl Alcohol

2gram Methyl Trenbolone 100ML @ 20mg/ml
3ml Benzyl Alcohol
95ml Grape seed oil

If you have any question pls feel free to contact me via:

Email: export@senwayer.com
Whats-app:+86-18186442580
Wickr me:yukis8888
We-chat:+86-18186442580
Tele-gram:+86-18186442580